Emek Medical Center

Afula 7177871

7 studies enrolling now · 20 studies all time

What they study most

Acute Gastrointestinal Bleeding, Acute Gout Flare, Advanced Non-Small Cell Lung Cancer, Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation, Arthritis, Atherosclerotic Cardiovascular Disease (ASCVD), Crohn's Disease, Diverticulitis, Elevated Lp(a), End Stage Kidney Disease, Gastric Outlet Obstruction, Gout

Studies at this site

• A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) — Recruiting now
• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin — Recruiting now
• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC — Recruiting now
• Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding — Recruiting now
• A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting — Recruiting now
• Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare — Recruiting now
• REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) — Running, not enrolling
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• EUS-GE vs ES for Palliation of Gastric Outlet Obstruction — Completed
• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
• IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18) — Running, not enrolling
• Study to Evaluate Safety & Tolerability of AGI-134 in Solid Tumour — Completed
• Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease — Stopped early
• Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease — Completed
• Study of Cilofexor in Adults With Primary Sclerosing Cholangitis — Stopped early
• Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV — Status unconfirmed
• Prevention of Recurrence of Diverticulitis — Completed
• Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Stopped early